Bentonite
Bentonite, licence 80047780: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Actumus Inc.
- NPN or DIN-HM
- 80047780
- Status
- Inactive licence
- Licence date
- 23 January 2014
- Revision date
- 14 January 2021
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bentonite Source : Bentonite | 1.0 g | Not calculated |
Non-medicinal ingredients
Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Cuillière(s) à table | 3.0 Jour(s) |
Uses authorised in Canada
Aide à soutenir la détoxification.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Peut causer de légers troubles gastrointestinaux tels que douleurs abdominales, ballonnements, constipation et diarrhée.
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptômes s¿aggravent. Cesser l'utilisation si vous souffrez de constipation. Consulter un praticien de soins de santé immédiatement si vous ressentez des douleurs thoraciques, des vomissements, ou de la difficulté à avaler ou à respirer après avoir pris ce produit. Si vous prenez des médicaments qui ralentissent le mouvement de l'intestin (p. ex. opiacés, lopéramide), ne pas utiliser. Si vous souffrez de constipation accompagnée de douleurs abdominales sévères, des nausées, de la fièvre ou des vomissements, ne pas utiliser. Ne pas utiliser si vous souffrez de diabète sucré dans lequel la glycémie est difficile à contrôler.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou allaitez ou si votre avez de la difficulté à avaler.
Source
Official Health Canada record, licence 80047780
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.